Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Ben-David, D., Kordevani, R., Keller, N., Tal, I., Marzel, A., Gal-Mor, O., Maor, Y., & Rahav, G. Clinical Microbiology and Infection, 18:54–60, 2012. doi abstract bibtex The aim of this study was to evaluate the impact of carbapenem-resistant K. pneumoniae bloodstream infections on mortality. During the study period 42, 68 and 120 patients were identified with carbapenem-resistant, extended-spectrum b-lactamase producers (ESBL) and susceptible K. pneumoniae bloodstream infections, respectively. Patients with carbapenem-resistant K. pneumoniae had higher rates of prior antimicrobial exposure, other nosocomial infections, and use of invasive devices. Infection-related mortality was 48% for carba-penem-resistant, 22% for ESBL producers and 17% for susceptible K. pneumoniae. Independent risk factors for infection-related mortality were Pitt bacteraemia score, Charlson score and carbapenem resistance.
@article{ben-david_outcome_2012,
title = {Outcome of carbapenem resistant {Klebsiella} pneumoniae bloodstream infections},
volume = {18},
doi = {10.1111/j.1469-0691.2011.03478.x},
abstract = {The aim of this study was to evaluate the impact of carbapenem-resistant K. pneumoniae bloodstream infections on mortality. During the study period 42, 68 and 120 patients were identified with carbapenem-resistant, extended-spectrum b-lactamase producers (ESBL) and susceptible K. pneumoniae bloodstream infections, respectively. Patients with carbapenem-resistant K. pneumoniae had higher rates of prior antimicrobial exposure, other nosocomial infections, and use of invasive devices. Infection-related mortality was 48\% for carba-penem-resistant, 22\% for ESBL producers and 17\% for susceptible K. pneumoniae. Independent risk factors for infection-related mortality were Pitt bacteraemia score, Charlson score and carbapenem resistance.},
journal = {Clinical Microbiology and Infection},
author = {Ben-David, D. and Kordevani, R. and Keller, N. and Tal, I. and Marzel, A. and Gal-Mor, O. and Maor, Y. and Rahav, G.},
year = {2012},
pages = {54--60},
}
Downloads: 0
{"_id":"N3TjqqNQZSjd6qAvv","bibbaseid":"bendavid-kordevani-keller-tal-marzel-galmor-maor-rahav-outcomeofcarbapenemresistantklebsiellapneumoniaebloodstreaminfections-2012","author_short":["Ben-David, D.","Kordevani, R.","Keller, N.","Tal, I.","Marzel, A.","Gal-Mor, O.","Maor, Y.","Rahav, G."],"bibdata":{"bibtype":"article","type":"article","title":"Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections","volume":"18","doi":"10.1111/j.1469-0691.2011.03478.x","abstract":"The aim of this study was to evaluate the impact of carbapenem-resistant K. pneumoniae bloodstream infections on mortality. During the study period 42, 68 and 120 patients were identified with carbapenem-resistant, extended-spectrum b-lactamase producers (ESBL) and susceptible K. pneumoniae bloodstream infections, respectively. Patients with carbapenem-resistant K. pneumoniae had higher rates of prior antimicrobial exposure, other nosocomial infections, and use of invasive devices. Infection-related mortality was 48% for carba-penem-resistant, 22% for ESBL producers and 17% for susceptible K. pneumoniae. Independent risk factors for infection-related mortality were Pitt bacteraemia score, Charlson score and carbapenem resistance.","journal":"Clinical Microbiology and Infection","author":[{"propositions":[],"lastnames":["Ben-David"],"firstnames":["D."],"suffixes":[]},{"propositions":[],"lastnames":["Kordevani"],"firstnames":["R."],"suffixes":[]},{"propositions":[],"lastnames":["Keller"],"firstnames":["N."],"suffixes":[]},{"propositions":[],"lastnames":["Tal"],"firstnames":["I."],"suffixes":[]},{"propositions":[],"lastnames":["Marzel"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Gal-Mor"],"firstnames":["O."],"suffixes":[]},{"propositions":[],"lastnames":["Maor"],"firstnames":["Y."],"suffixes":[]},{"propositions":[],"lastnames":["Rahav"],"firstnames":["G."],"suffixes":[]}],"year":"2012","pages":"54–60","bibtex":"@article{ben-david_outcome_2012,\n\ttitle = {Outcome of carbapenem resistant {Klebsiella} pneumoniae bloodstream infections},\n\tvolume = {18},\n\tdoi = {10.1111/j.1469-0691.2011.03478.x},\n\tabstract = {The aim of this study was to evaluate the impact of carbapenem-resistant K. pneumoniae bloodstream infections on mortality. During the study period 42, 68 and 120 patients were identified with carbapenem-resistant, extended-spectrum b-lactamase producers (ESBL) and susceptible K. pneumoniae bloodstream infections, respectively. Patients with carbapenem-resistant K. pneumoniae had higher rates of prior antimicrobial exposure, other nosocomial infections, and use of invasive devices. Infection-related mortality was 48\\% for carba-penem-resistant, 22\\% for ESBL producers and 17\\% for susceptible K. pneumoniae. Independent risk factors for infection-related mortality were Pitt bacteraemia score, Charlson score and carbapenem resistance.},\n\tjournal = {Clinical Microbiology and Infection},\n\tauthor = {Ben-David, D. and Kordevani, R. and Keller, N. and Tal, I. and Marzel, A. and Gal-Mor, O. and Maor, Y. and Rahav, G.},\n\tyear = {2012},\n\tpages = {54--60},\n}\n\n\n\n","author_short":["Ben-David, D.","Kordevani, R.","Keller, N.","Tal, I.","Marzel, A.","Gal-Mor, O.","Maor, Y.","Rahav, G."],"key":"ben-david_outcome_2012-1","id":"ben-david_outcome_2012-1","bibbaseid":"bendavid-kordevani-keller-tal-marzel-galmor-maor-rahav-outcomeofcarbapenemresistantklebsiellapneumoniaebloodstreaminfections-2012","role":"author","urls":{},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/FRGBergamini","dataSources":["o2mL7kG99iAQPpNRJ"],"keywords":[],"search_terms":["outcome","carbapenem","resistant","klebsiella","pneumoniae","bloodstream","infections","ben-david","kordevani","keller","tal","marzel","gal-mor","maor","rahav"],"title":"Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections","year":2012}